Asset Details
Do you wish to reserve the book?
Osteogenesis imperfecta
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Osteogenesis imperfecta
Do you wish to request the book?
Osteogenesis imperfecta
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Osteogenesis imperfecta
2016
Overview
Osteogenesis imperfecta is a phenotypically and molecularly heterogeneous group of inherited connective tissue disorders that share similar skeletal abnormalities causing bone fragility and deformity. Previously, the disorder was thought to be an autosomal dominant bone dysplasia caused by defects in type I collagen, but in the past 10 years discoveries of novel (mainly recessive) causative genes have lent support to a predominantly collagen-related pathophysiology and have contributed to an improved understanding of normal bone development. Defects in proteins with very different functions, ranging from structural to enzymatic and from intracellular transport to chaperones, have been described in patients with osteogenesis imperfecta. Knowledge of the specific molecular basis of each form of the disorder will advance clinical diagnosis and potentially stimulate targeted therapeutic approaches. In this Seminar, together with diagnosis, management, and treatment, we describe the defects causing osteogenesis imperfecta and their mechanism and interrelations, and classify them into five groups on the basis of the metabolic pathway compromised, specifically those related to collagen synthesis, structure, and processing; post-translational modification; folding and cross-linking; mineralisation; and osteoblast differentiation.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
Bone Density Conservation Agents - therapeutic use
/ Bones
/ Calcification, Physiologic - genetics
/ Cell Differentiation - genetics
/ Collagen
/ Genes
/ Genetic Predisposition to Disease
/ Humans
/ Mutation
/ Osteogenesis Imperfecta - diagnosis
/ Osteogenesis Imperfecta - genetics
/ Osteogenesis Imperfecta - therapy
/ Protein Processing, Post-Translational - genetics
/ Proteins
